Open access · CC-BY
via OpenAlex
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease
Silke Frahm, Valeria Melis, David Horsley, Janet E. Rickard, Gernot Riedel, Paola Fadda, María Scherma, Charles R. Harrington, Claude M. Wischik, Franz Theuring, Karima Schwab
Behavioural Brain Research · 2017 · ▲ 28 citations
Abstract
Alpha-Synuclein (α-Syn) accumulation is considered a major risk factor for the development of synucleinopathies such as Parkinson's disease (PD) and dementia with Lewy bodies. We have generated mice overexpressing full-length human α-Syn fused to a membrane-targeting signal sequence under the control of the mouse Thy1-promotor. Three separate lines (L56, L58 and L62) with similar gene expression levels, but considerably heightened protein accumulation in L58 and L62, were established. In L62, there was widespread labelling of α-Syn immunoreactivity in brain including spinal cord, basal forebrain, cortex and striatum. Interestingly, there was no detectable α-Syn expression in dopaminergic neurones of the substantia nigra, but strong human α-Syn reactivity in glutamatergic synapses. The human α-Syn accumulated during aging and formed PK-resistant, thioflavin-binding aggregates. Mice displayed early onset bradykinesia and age progressive motor deficits. Functional alterations within the striatum were confirmed: L62 showed normal basal dopamine levels, but impaired dopamine release (upon amphetamine challenge) in the dorsal striatum measured by in vivo brain dialysis at 9 months of age. This impairment was coincident with a reduced response to amphetamine in the activity test. L62 further displayed greater sensitivity to low doses of the dopamine receptor 1 (D1) agonist SKF81297 but reacted normally to the D2 agonist quinpirole in the open field. Since accumulation of α-Syn aggregates in neurones and synapses and alterations in the dopaminergic tone are characteristics of PD, phenotypes reported for L62 present a good opportunity to further our understanding of motor dysfunction in PD and Lewy body dementia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.bbr.2017.11.025
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Frahm, S., Melis, V., Horsley, D., Rickard, J.E., Riedel, G., Fadda, P., Scherma, M., Harrington, C.R., Wischik, C.M., Theuring, F., & Schwab, K. (2017). Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease. <em>Behavioural Brain Research</em>. https://doi.org/10.1016/j.bbr.2017.11.025
Vancouver
Frahm S, Melis V, Horsley D, Rickard JE, Riedel G, Fadda P, et al. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease. Behavioural Brain Research. 2017. doi:10.1016/j.bbr.2017.11.025.
BibTeX
@article{silke2017AlphaS,
title = {Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease},
author = {Silke Frahm and Valeria Melis and David Horsley and Janet E. Rickard and Gernot Riedel and Paola Fadda and María Scherma and Charles R. Harrington and Claude M. Wischik and Franz Theuring and Karima Schwab},
journal = {Behavioural Brain Research},
year = {2017},
doi = {10.1016/j.bbr.2017.11.025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neuroscience 2003
Open access · OA
Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons
Parkinson s Disease 2016
Open access · CC-BY
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Journal of Neuroscience 2004
Open access · CC-BY
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Frontiers in Neuroscience 2018
Open access · CC-BY
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
International Journal of Molecular Sciences 2021
Open access · CC-BY
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
Biomolecules 2015
Open access · CC-BY